TNFα promotes osteosarcoma progression by maintaining tumor cells in an undifferentiated state
Authors:
Open Access
- 16 December 2013
- journal article
- research article
- Published by Springer Nature in Oncogene
- Vol. 33 (33) , 4236-4241
Abstract
Chronic inflammation is frequently associated with tumorigenesis in elderly people. By contrast, young people without chronic inflammation often develop tumors considered independent of chronic inflammation but driven instead by mutations. Thus, whether inflammation has a significant role in tumor progression in tumors driven by mutations remains largely unknown. Here we show that TNFα is required for the tumorigenesis of osteosarcoma, the most common tumor in children and adolescents. We show that transplantation of AX osteosarcoma cells, which harbor mutations driving c-Myc overexpression and Ink4a-deficiency, in wild-type mice promotes lethal tumorigenesis accompanied by ectopic bone formation and multiple metastases, phenotypes seen in osteosarcoma patients. Such tumorigenesis was completely abrogated in TNFα-deficient mice. AX cells have the capacity to undergo osteoblastic differentiation; however, that activity was significantly inhibited by TNFα treatment, suggesting that TNFα maintains AX cells in an undifferentiated state. TNFα inhibition of AX cell osteoblastic differentiation occurred through ERK activation, and a pharmacological TNFα inhibitor effectively inhibited both AX cell tumorigenesis and increased osteoblastic gene expression and increased survival of tumor-bearing mice. Lethal tumorigenesis of AX cells was also abrogated in IL-1α/IL-1β doubly deficient mice. We found that both TNFα and IL-1 maintained AX cells in an undifferentiated state via ERK activation. Thus, inflammatory cytokines are required to promote tumorigenesis even in mutation-induced tumors, and TNFα/IL-1 and ERK may represent therapeutic targets for osteosarcoma.Keywords
This publication has 29 references indexed in Scilit:
- Molecular Link Mechanisms between Inflammation and CancerCurrent Pharmaceutical Design, 2012
- Retrospective analysis of metastatic sarcoma patientsOncology Letters, 2011
- Diverse somatic mutation patterns and pathway alterations in human cancersNature, 2010
- The Epidemiology of Osteosarcoma2009
- Osteosarcoma incidence and survival rates from 1973 to 2004Cancer, 2009
- Inflammation, ageing and cancerMechanisms of Ageing and Development, 2009
- Imaging findings of extrapulmonary metastases of osteosarcomaClinical Imaging, 2004
- Cytokine and cytokine receptor serum levels in adult bone sarcoma patients: Correlations with local tumor extent and prognosisJournal of Surgical Oncology, 2003
- Pathology of OsteosarcomaClinical Orthopaedics and Related Research, 1975
- Histological and Dosimetric Considerations of Bone Tumour Production with Radioactive PhosphorusBritish Journal of Radiology, 1961